Enyglid

Enyglid is a medication containing repaglinide, used to manage blood sugar levels in adults with type 2 diabetes. This oral medication helps control glucose levels by stimulating insulin release from the pancreas.

Enyglid is primarily used to manage blood sugar levels in adults with type 2 diabetes. It works by stimulating the pancreas to release more insulin, which helps to lower blood sugar levels. This medication is often prescribed as part of a comprehensive diabetes management plan, which may include diet and exercise.

Common effects of Enyglid may include hypoglycemia, or low blood sugar, which can cause symptoms such as sweating, dizziness, and hunger. Other potential effects include headache, nausea, and upper respiratory infections. It is important to monitor blood sugar levels regularly while taking this medication.

Enyglid should be handled with care, especially for individuals with a history of liver or kidney problems. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Regular monitoring of blood sugar levels is essential to avoid hypoglycemia.

Enyglid may interact with other medications, including those that affect blood sugar levels, such as insulin or other diabetes medications. It is also important to be cautious when consuming alcohol, as it can increase the risk of hypoglycemia. Always inform your healthcare provider about all medications and supplements you are taking.